biophBiomedical PhotonicsBiomedical Photonics2413-9432Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis10.24931/2413-9432-2022-11-1-27-36bioph-532Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSФотодинамическая терапия в лечении больных грибовидным микозомPhotodynamic therapy in the treatment of patients with mycosis fungoidesФилоненкоЕ. В.FilonenkoE. V.

Москва

Moscow

derkul23@yandex.ruИванова-РадкевичВ. И.Ivanova-RadkevichV. I.

Москва

Moscow

«Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Министерства здравоохранения Российской ФедерацииРоссияP.A. Herzen Moscow Oncology Research Center – branch of FSBI NMRRC of the Ministry of Health of the Russian FederationRussian FederationРоссийский Университет дружбы народовРоссияPeoples’ Friendship University of Russia (RUDN University)Russian Federation2022250520221112736Copyright © Филоненко Е.В., Иванова-Радкевич В.И., 20222022Филоненко Е.В., Иванова-Радкевич В.И.Filonenko E.V., Ivanova-Radkevich V.I.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pdt-journal.com/jour/article/view/532

В обзоре освещены современные представления об эпидемиологии, этиологии, патогенезе, существующих классификациях грибовидного микоза. Описаны методы диагностики и лечения патологии, важную роль среди которых играет фотодинамическая терапия (ФДТ). К основным преимуществам ФДТ грибовидного микоза относятся отсутствие системной токсичности, неинвазивность, избирательность действия, отсутствие канцерогенного потенциала, возможность проведения повторных курсов лечения и хорошие косметические результаты. В настоящем обзоре собраны и проанализированы результаты клинических исследований ФДТ пациентов с грибовидным микозом. Анализ показал высокую эффективность ФДТ у пациентов с грибовидным микозом с изолированными или ограниченными пятнами и бляшками. ФДТ можно рассматривать как терапию выбора у пациентов с очагами на лице, когда одним из основных требований является хороший косметический результат, а лучевая терапия, азотный иприт или кармустин могут оставить постоянные и видимые шрамы. Бляшки, расположенные в подмышечных или паховых складках кожи, недоступные для фототерапии, также можно лечить с помощью ФДТ.

The review highlights the current understanding of the epidemiology, etiology, pathogenesis, existing classifications of mycosis fungoides. Methods for diagnosis and treatment of the pathology are described, among which photodynamic therapy (PDT) plays an important role. The main advantages of PDT for mycosis fungoides include the absence of systemic toxicity, non-invasiveness, selectivity, absence of carcinogenic potential, the possibility of repeated courses of treatment, and good cosmetic results. This review collects and analyzes the results of clinical trials of PDT in patients with mycosis fungoides. The analysis showed high efficiency of PDT in patients with mycosis fungoides with isolated or limited spots and plaques. PDT can be considered as the therapy of choice in patients with facial lesions when a good cosmetic result is one of the main requirements, and radiation therapy, nitrogen mustard or carmustine can leave permanent and visible scars. Plaques located in the axillary or inguinal skin folds that are inaccessible to phototherapy can also be treated with PDT.

фотодинамическая терапиягрибовидный микоз5-аминолевулиновая кислотаphotodynamic therapymycosis fungoides5-aminolevulinic acidReferencesLarocca C., Kupper T., Mycosis Fungoides and Sézary Syndrome // Hematol Oncol Clin North Am. – 2019. – Vol. 33(1). – P.103-120. doi: 10.1016/j.hoc.2018.09.001Larocca C., Kupper T., Mycosis Fungoides and Sézary Syndrome // Hematol Oncol Clin North Am. – 2019. – Vol. 33(1). – P.103-120. doi: 10.1016/j.hoc.2018.09.001Keehn C.A., Belongie I.P., Shistik G. et al. The diagnosis, staging, and treatment options for mycosis fungoides // Cancer Control. – 2007. – Vol. 14(2). – P.102-111.Keehn C.A., Belongie I.P., Shistik G. et al. The diagnosis, staging, and treatment options for mycosis fungoides // Cancer Control. – 2007. – Vol. 14(2). – P.102-111.Korgavkar K., Xiong M., Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma // JAMA Dermatol. – 2013. – Vol. 149(11). – P.1295-1299.Korgavkar K., Xiong M., Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma // JAMA Dermatol. – 2013. – Vol. 149(11). – P.1295-1299.Hristov A.C., Tejasvi T., Wilcox R.A. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management // Am J Hematol. – 2019. – Vol. 94(9). – P.1027-1041. doi: 10.1002/ajh.25577Hristov A.C., Tejasvi T., Wilcox R.A. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management // Am J Hematol. – 2019. – Vol. 94(9). – P.1027-1041. doi: 10.1002/ajh.25577Willemze R., Jaffe E.S., Burg G. et al. WHO-EORTC classification for cutaneous lymphomas. Blood. – 2005. – Vol. 105(10). – P. 3768- 3785.Willemze R., Jaffe E.S., Burg G. et al. WHO-EORTC classification for cutaneous lymphomas. Blood. – 2005. – Vol. 105(10). – P. 3768- 3785.Fernández-Guarino M., Jaén-Olasolo P. Photodynamic therapy in mycosis fungoides // Actas Dermosifiliogr. – 2013. – Vol. 104(5). – P. 393-399. doi:10.1016/j.adengl.2012.11.017Fernández-Guarino M., Jaén-Olasolo P. Photodynamic therapy in mycosis fungoides // Actas Dermosifiliogr. – 2013. – Vol. 104(5). – P. 393-399. doi:10.1016/j.adengl.2012.11.017Glusac E.J. Criterion by criterion, mycosis fungoides. Am J Dermatopathol. – 2003. – Vol. 25. – P. 264-269.Glusac E.J. Criterion by criterion, mycosis fungoides. Am J Dermatopathol. – 2003. – Vol. 25. – P. 264-269.Kim E.J., Lin J., Junkins-Hopkins J.M. et al. Mycosis fungoides and Sezary syndrome: an update // Curr Oncol Rep. – 2006. – Vol. 8. – P. 376-386.Kim E.J., Lin J., Junkins-Hopkins J.M. et al. Mycosis fungoides and Sezary syndrome: an update // Curr Oncol Rep. – 2006. – Vol. 8. – P. 376-386.Trautinger F., Knobler R., Willemze R. et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome // Eur J Cancer. – 2006. – Vol. 42. – P. 1014-1030.Trautinger F., Knobler R., Willemze R. et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome // Eur J Cancer. – 2006. – Vol. 42. – P. 1014-1030.Olsen E., Vonderheid E., Pimpinelli N. et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous task force of the European Organization for Research and Treatment of Cancer (EORTC) // Blood. – 2007). – Vol. 110. – P. 1713-1722. http://dx.doi.org/10.1182/blood-2007-03-05574+9Olsen E., Vonderheid E., Pimpinelli N. et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous task force of the European Organization for Research and Treatment of Cancer (EORTC) // Blood. – 2007). – Vol. 110. – P. 1713-1722. http://dx.doi.org/10.1182/blood-2007-03-05574+9Olsen E., Whittaker S., Kim Y., Duvic M., Prince H.M., Lessin S.R. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphoma, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer // J Clin Oncol. – 2011. – Vol. 29. – P. 2598-2607. http://dx.doi.org/10.1200/JCO.2010.32.0630Olsen E., Whittaker S., Kim Y., Duvic M., Prince H.M., Lessin S.R. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphoma, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer // J Clin Oncol. – 2011. – Vol. 29. – P. 2598-2607. http://dx.doi.org/10.1200/JCO.2010.32.0630Sausville E.A., Eddy J.L., Makuch R.W. Histopathologic diagnosis of mycosis fungoides and Sézary syndrome: definition of three distinctive prognostic groups // Ann Intern Med. – 1998. – Vol. 109. – P. 372-382.Sausville E.A., Eddy J.L., Makuch R.W. Histopathologic diagnosis of mycosis fungoides and Sézary syndrome: definition of three distinctive prognostic groups // Ann Intern Med. – 1998. – Vol. 109. – P. 372-382.Horwitz S.M., Olsen E.A., Duvic M., Porcu P., Kim Y.H. Review of the treatment of mycosis fungoides and Sézary syndrome: a stagebased approach // J Natl Compr Canc Netw. – 2008. – Vol. 6. – P.436-442.Horwitz S.M., Olsen E.A., Duvic M., Porcu P., Kim Y.H. Review of the treatment of mycosis fungoides and Sézary syndrome: a stagebased approach // J Natl Compr Canc Netw. – 2008. – Vol. 6. – P.436-442.Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions // J Am Acad Dermatol. – 2014. – Vol. 70(2). – P. 223–240. doi: 10.1016/j.jaad.2013.08.033Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions // J Am Acad Dermatol. – 2014. – Vol. 70(2). – P. 223–240. doi: 10.1016/j.jaad.2013.08.033Chiarion-Sileni V., Bononi A., Fornasa C.V., Soraru M., Alaibac M., Ferrazzi E. et al. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma // Cancer. – 2002. – Vol. 95. – P. 569-575.Chiarion-Sileni V., Bononi A., Fornasa C.V., Soraru M., Alaibac M., Ferrazzi E. et al. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma // Cancer. – 2002. – Vol. 95. – P. 569-575.Kaufmann F., Kettelhack N., Hilty N., Kempf W. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature // J Eur Acad Dermatol Venereol. – 2017. – Vol. 31(10). – P. 1633-1637. doi: 10.1111/jdv.14160.Kaufmann F., Kettelhack N., Hilty N., Kempf W. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature // J Eur Acad Dermatol Venereol. – 2017. – Vol. 31(10). – P. 1633-1637. doi: 10.1111/jdv.14160.Kim S.T., Kang D.Y., Kang J.S., Baek J.W., Jeon Y.S., Suh K.S. Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides // Acta Derm Venereol. – 2012. – Vol. 92(3). – P. 264- 268. doi: 10.2340/00015555-1261Kim S.T., Kang D.Y., Kang J.S., Baek J.W., Jeon Y.S., Suh K.S. Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides // Acta Derm Venereol. – 2012. – Vol. 92(3). – P. 264- 268. doi: 10.2340/00015555-1261Rhodes L.E., de Rie M., Enstrom Y., Groves R., Morken T., Goulden V. et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial // Arch Dermatol. – 2004. – Vol. 140. – P. 17-23.Rhodes L.E., de Rie M., Enstrom Y., Groves R., Morken T., Goulden V. et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial // Arch Dermatol. – 2004. – Vol. 140. – P. 17-23.Fritsch C., Homey B., Stahl W., Lehmann P., Ruzicka T., Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester // Photochem Photobiol. – 1998. – Vol. 68. – P. 218-221.Fritsch C., Homey B., Stahl W., Lehmann P., Ruzicka T., Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester // Photochem Photobiol. – 1998. – Vol. 68. – P. 218-221.Freeman M., Vinciullo C., Francis D., Spelman L., Nguyen R., Fergin P. et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study // J Dermatolog Treat. – 2003. – Vol. 14. – P. 99-106.Freeman M., Vinciullo C., Francis D., Spelman L., Nguyen R., Fergin P. et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study // J Dermatolog Treat. – 2003. – Vol. 14. – P. 99-106.Boehncke W.H., Koeing K., Ruck A., Kauffman R., Sterry W. In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma // Acta Derm Venereol. – 1994. – Vol. 74. – P. 201-205.Boehncke W.H., Koeing K., Ruck A., Kauffman R., Sterry W. In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma // Acta Derm Venereol. – 1994. – Vol. 74. – P. 201-205.Lam M., Lee Y., Deng M., Hsia A.H., Morrissey K.A., Yan C., Azzizudin K., Oleinick N.L., McCormick T.S., Cooper K.D., Baron E.D. Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome // Adv Hematol. – 2010 – Vol. 896161. doi: 10.1155/2010/896161Lam M., Lee Y., Deng M., Hsia A.H., Morrissey K.A., Yan C., Azzizudin K., Oleinick N.L., McCormick T.S., Cooper K.D., Baron E.D. Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome // Adv Hematol. – 2010 – Vol. 896161. doi: 10.1155/2010/896161Rittenhouse-Diakun K., Van Leengoed H., Morgan J., Hryhorenko E., Paszkiewicz G., Whitaker J.E. et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA) // Photochem Photobiol. – 1995. – Vol. 61. – P. 523-528.Rittenhouse-Diakun K., Van Leengoed H., Morgan J., Hryhorenko E., Paszkiewicz G., Whitaker J.E. et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA) // Photochem Photobiol. – 1995. – Vol. 61. – P. 523-528.Leibovici L., Shoenfeld N., Yehoshua H.A. et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer // Cancer. –1988. – Vol. 62. – P. 2297-2300.Leibovici L., Shoenfeld N., Yehoshua H.A. et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer // Cancer. –1988. – Vol. 62. – P. 2297-2300.Lopez R.V., Lange N., Guy R., Bentley M.V. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters // Adv Drug Del Rev. – 2004. – Vol. 56. – P. 77-94.Lopez R.V., Lange N., Guy R., Bentley M.V. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters // Adv Drug Del Rev. – 2004. – Vol. 56. – P. 77-94.Pariser D.M., Lowe N.J., Stewart D.M. et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial // J Am Acad Dermatol. – 2003. – Vol. 17. – P. 45-56.Pariser D.M., Lowe N.J., Stewart D.M. et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial // J Am Acad Dermatol. – 2003. – Vol. 17. – P. 45-56.Ammann R., Hunziker T.H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid // J Am Acad Dermatol. – 1995. – Vol. 33. – P. 541.Ammann R., Hunziker T.H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid // J Am Acad Dermatol. – 1995. – Vol. 33. – P. 541.Díez-Recio E., Zambrano B., Alonso M.L., De Eusebio E., Martín M., Cuevas J., Jaén P. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature // Int J Dermatol. – 2008. – Vol. 47. – P. 410-413. http://dx.doi.org/10.1111/j.1365-4632.2008.03177.x.Díez-Recio E., Zambrano B., Alonso M.L., De Eusebio E., Martín M., Cuevas J., Jaén P. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature // Int J Dermatol. – 2008. – Vol. 47. – P. 410-413. http://dx.doi.org/10.1111/j.1365-4632.2008.03177.x.Edstrom D.W., Portwit A., Ros A.M. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response // Acta Derm Venereol. – 2001. – Vol. 81. – P. 184-188.Edstrom D.W., Portwit A., Ros A.M. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response // Acta Derm Venereol. – 2001. – Vol. 81. – P. 184-188.Eich D., Eich H.T., Otte T.H., Ghilescu H.G., Stadler R. Photodynamishce Terapie kuntaker T-Zell-Lymphome in besonderer Lokalisation // Hautarzt. – 1999. – Vol. 50. – P. 109-114.Eich D., Eich H.T., Otte T.H., Ghilescu H.G., Stadler R. Photodynamishce Terapie kuntaker T-Zell-Lymphome in besonderer Lokalisation // Hautarzt. – 1999. – Vol. 50. – P. 109-114.Svanberg K., Andersson T., Killander D., Wang I., Stenram U., Aderson-Engels S., Berg R., Johansson J., Svanberg S. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolaevulinic acid sensitization and laser irradiation // Br J Dermatol. – 1994. – Vol. 130. – P. 743-751.Svanberg K., Andersson T., Killander D., Wang I., Stenram U., Aderson-Engels S., Berg R., Johansson J., Svanberg S. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolaevulinic acid sensitization and laser irradiation // Br J Dermatol. – 1994. – Vol. 130. – P. 743-751.Wolf P., Fink-Puches R., Cerroni L., Kerl H. Photodynamic therapy for mycosis fungoides after photosensitization with 5-aminolevulinic acid // J Am Acad Dermatol. – 1994. – Vol. 31. – P. 678-680.Wolf P., Fink-Puches R., Cerroni L., Kerl H. Photodynamic therapy for mycosis fungoides after photosensitization with 5-aminolevulinic acid // J Am Acad Dermatol. – 1994. – Vol. 31. – P. 678-680.Wang I., Bauer B., Anderson-Engels S. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin // Acta Oftalm Scan. – 1999. – Vol. 77. – P. 182-188.Wang I., Bauer B., Anderson-Engels S. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin // Acta Oftalm Scan. – 1999. – Vol. 77. – P. 182-188.Orestein A., Haik J., Tamir J. et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application // Dermatol Surg. – 2000. – Vol. 26. – P. 765-769.Orestein A., Haik J., Tamir J. et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application // Dermatol Surg. – 2000. – Vol. 26. – P. 765-769.Markham T., Sheehan K., Collins P. Topical 5-aminolevulinic acid photodynamic therapy for tumor-stage mycosis fungoides // Br J Dermatol. – 2001. – Vol. 144. – P. 1262.Markham T., Sheehan K., Collins P. Topical 5-aminolevulinic acid photodynamic therapy for tumor-stage mycosis fungoides // Br J Dermatol. – 2001. – Vol. 144. – P. 1262.Leman J.A., Dick D.C., Morton C.A. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma // Clin Exp Dermatol. – 2002. – Vol. 27. – P. 516-518.Leman J.A., Dick D.C., Morton C.A. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma // Clin Exp Dermatol. – 2002. – Vol. 27. – P. 516-518.Coors E.A., Von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma // J Am Acad Dermatol. – 2004. – Vol. 50. – P. 363-367. http://dx.doi.org/10.1016/S0190Coors E.A., Von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma // J Am Acad Dermatol. – 2004. – Vol. 50. – P. 363-367. http://dx.doi.org/10.1016/S0190Zane C., Venturini M., Sala R., Calzavara-Pinton P. Photodynamic therapy with mehtylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma // Photodermatol Photoinmunol Photomed. – 2006. – Vol. 22. – P. 254-258.Zane C., Venturini M., Sala R., Calzavara-Pinton P. Photodynamic therapy with mehtylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma // Photodermatol Photoinmunol Photomed. – 2006. – Vol. 22. – P. 254-258.Fernández-Guarino M., Harto A., Pérez-García B., Montull C., Jaén P. Plaque-phase mycosis fungoides treated with photodynamic therapy: results in 12 patients // Actas dermosifiliogr. – 2010. – Vol. 9. – P. 785-791.Fernández-Guarino M., Harto A., Pérez-García B., Montull C., Jaén P. Plaque-phase mycosis fungoides treated with photodynamic therapy: results in 12 patients // Actas dermosifiliogr. – 2010. – Vol. 9. – P. 785-791.Quéreux G., Brocard A., Saint-Jean M., Peuvrel L., Knol A., Allix R., Khammari A., Renaut J., Dréno B. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature // J Am Acad Dermatol. – 2013. – Vol. 69(6). – P. 890-897. doi: 10.1016/j.jaad.2013.07.047.Quéreux G., Brocard A., Saint-Jean M., Peuvrel L., Knol A., Allix R., Khammari A., Renaut J., Dréno B. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature // J Am Acad Dermatol. – 2013. – Vol. 69(6). – P. 890-897. doi: 10.1016/j.jaad.2013.07.047.Pileri A., Sgubbi P., Agostinelli C., Salvatore D.I., Vaccari S., Patrizi A. Photodynamic therapy: an option in mycosis fungoides // Photodiagnosis and Photodynamic Therapy. – 2017. – Vol. 20. – P. 107- 110. http://dx.doi.org/10.1016/j.pdpdt.2017.09.004Pileri A., Sgubbi P., Agostinelli C., Salvatore D.I., Vaccari S., Patrizi A. Photodynamic therapy: an option in mycosis fungoides // Photodiagnosis and Photodynamic Therapy. – 2017. – Vol. 20. – P. 107- 110. http://dx.doi.org/10.1016/j.pdpdt.2017.09.004Hegyi J., Frey T., Arenberger P. Unilesional mycosis fungoides treated with photodynamic therapy. A case report // Acta Dermatovenerol Alp Pannonica Adriat. – 2008. – Vol. 17(2). – P. 75-78.Hegyi J., Frey T., Arenberger P. Unilesional mycosis fungoides treated with photodynamic therapy. A case report // Acta Dermatovenerol Alp Pannonica Adriat. – 2008. – Vol. 17(2). – P. 75-78.Jang M.S., Jang J.Y., Park J.B., Kang D.Y., Lee J.W., Lee T.G., Hwangbo H., Suh K.S. Erratum: Folliculotropic Mycosis Fungoides in 20 Korean Cases: Clinical and Histopathologic Features and Response to Ultraviolet A-1 and/or Photodynamic Therapy // Ann Dermatol. – 2018. – Vol. 30(4). – P. 510. doi: 10.5021/ad.2018.30.4.510.Jang M.S., Jang J.Y., Park J.B., Kang D.Y., Lee J.W., Lee T.G., Hwangbo H., Suh K.S. Erratum: Folliculotropic Mycosis Fungoides in 20 Korean Cases: Clinical and Histopathologic Features and Response to Ultraviolet A-1 and/or Photodynamic Therapy // Ann Dermatol. – 2018. – Vol. 30(4). – P. 510. doi: 10.5021/ad.2018.30.4.510.

The authors declare that there are no conflicts of interest present.